MARATTO

article · Journal of the Pakistan Medical Association

Physical activity limitations in children with severe hemophilia A. does emicizumab make a difference?

20234 citationsOpen accessKafr el-Sheikh University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Emicizumab prophylaxis improved the level of physical activity in children with severe haemophilia A.

Research topics

  • Hemophilia Treatment and Research
  • Adolescent and Pediatric Healthcare

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.47391/jpma.egy-s4-10

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.